Rhumbline Advisers boosted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.3% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,533,800 shares of the pharmacy operator’s stock after buying an additional 63,259 shares during the period. Rhumbline Advisers owned approximately 0.14% of Walgreens Boots Alliance worth $120,112,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Reilly Financial Advisors LLC boosted its stake in Walgreens Boots Alliance by 7.9% during the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after purchasing an additional 100 shares during the last quarter. Webster Bank N. A. boosted its stake in Walgreens Boots Alliance by 18.4% during the 1st quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock valued at $125,000 after purchasing an additional 235 shares during the last quarter. Orrstown Financial Services Inc. boosted its stake in shares of Walgreens Boots Alliance by 14.1% in the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 213 shares during the last quarter. MCF Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 68.2% in the 1st quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock worth $160,000 after buying an additional 780 shares during the last quarter. Finally, Founders Capital Management purchased a new position in shares of Walgreens Boots Alliance in the 1st quarter worth $161,000. 60.14% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This news story was first published by BBNS and is the property of of BBNS. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://baseballnewssource.com/markets/rhumbline-advisers-buys-63259-shares-of-walgreens-boots-alliance-inc-wba/1700520.html.
A number of equities analysts have recently issued reports on the company. Needham & Company LLC set a $94.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Monday, July 17th. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday. Pivotal Research set a $85.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Sunday, July 2nd. Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Finally, Morgan Stanley reiterated an “overweight” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average target price of $90.18.
Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at 67.40 on Wednesday. The firm’s 50 day moving average price is $78.27 and its 200 day moving average price is $80.61. Walgreens Boots Alliance, Inc. has a 12 month low of $66.92 and a 12 month high of $89.69. The stock has a market cap of $72.12 billion, a price-to-earnings ratio of 17.02 and a beta of 1.25.
Walgreens Boots Alliance announced that its board has approved a share repurchase program on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its shares are undervalued.
In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the transaction, the director now directly owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 13.50% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with our FREE daily email newsletter.